Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer
Clinical trial NCT05503888 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05503888
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2027-07-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.